"The voice of oncology in Massachusetts."


MSCO continuously contacts legislators, provides comments to policy makers and collaborates with payers on issues of concern to those delivering care to cancer patients.  The Society's affiliation with national advocacy groups allows us to bring our local issues to a wider forum and benefit from the resources of these organizations.

Below we are providing alerts to relevant legislation and policy, provide resources and detail ways members can action. It is critical that providers support these efforts for their patients ant their practices. 

Calls to action

  • June 01, 2023 10:48 AM | Katy Monaco (Administrator)

    We know many of you have been struggling with getting your patients the treatments they need due to ongoing drug shortages. ASCO has been working with policymakers on the current state of oncology drug shortages and we need your help! A bipartisan group of Representatives are circulating a “Dear Colleague Letter” addressed to the Food and Drug Administration (FDA) Commissioner Dr. Robert Califf sharing concerns and asking the FDA to identify additional flexibilities and authorities needed to prevent or mitigate future shortages.

    Please ask your Representative to sign the letter and urge your Senators to work with their colleagues to take steps to mitigate drug shortages!

  • May 04, 2023 11:38 AM | Katy Monaco (Administrator)

    By prohibiting co-pay assistance funds from applying toward patient premiums and deductibles, co-pay accumulators negate the intended benefit of patient assistance programs and remove a safety net for patients who need specialty medications but cannot afford them. Contact your lawmakers to cosponsor the HELP Copays Act to end these harmful practices and address high out of pocket costs for patients.

  • May 04, 2023 11:36 AM | Katy Monaco (Administrator)

    ASCO and the broader medical community are asking Congress to take steps that will streamline the prior authorization process within the Medicare Advantage program, including:

    • Creating an electronic prior authorization process.
    • Holding plans accountable for the timeliness of determinations.
    • Improving transparency by requiring plans to report to the Centers for Medicare and Medicaid Services (CMS) on the extent of their prior authorization use.
    • Prohibiting additional prior authorization for added medically necessary services performed during an invasive procedure that already received prior authorization.

    Contact your lawmakers to sign the Dear Colleague letters urging CMS to streamline prior authorization requirements in Medicare Advantage.

  • May 04, 2023 11:22 AM | Katy Monaco (Administrator)

    Right now, members of Congress are negotiating their next budget bill. Make sure they know cancer research and prevention needs to be a priority.  Send a message to your members of Congress today!

    Thanks to sustained federal funding for cancer research over the past few decades, we have made significant progress in understanding cancer and how best to treat it. But significant isn’t enough; we can’t stop now.

    Additional funding for cancer research means scientists can do even more in their work to find new ways to prevent, diagnose and treat cancer. And it means more hope for those facing the disease, now and in the future.

  • April 28, 2023 10:17 AM | Katy Monaco (Administrator)

    Physician members of the House of Representatives recently introduced legislation to address physician Medicare reimbursement not keeping up with the growing rate of inflation. Representatives Larry Bucshon, MD (R-IN), Raul Ruiz, MD (D-CA), Marionette Miller-Meeks, MD (R-IA) and Ami Bera, MD (D-CA) introduced H.R. 2474, which aims to provide annual inflationary updates based on the Medicare Economic Index (MEI) for Medicare physician services to ensure reimbursements are more aligned with economic inflation rates. For years, physician reimbursement under Medicare has not remained consistent with the rise in inflation, leading to payment instability across all physician specialties. While there are other concerns with the Medicare physician payment system that still need to be addressed, this legislation is the first step toward improving financial stability in physician practices, which will allow them to invest in how they deliver high-quality care. ASCO applauds Congress’ action to address this issue and joined many other physician organizations to sign on to a letter of support for the legislation. ASCO will work with the physician community to gain support for this legislation and to advance other policy solutions to improve the Medicare payment system. Join in our advocacy efforts! Write to your lawmaker via the ACT Network urging them to cosponsor H.R. 2474.

ASCO in Action

It is always vital that you engage with your lawmakers to ask them to help advance priority issues for the cancer care community.


ASCO’s Advocacy Toolkit: Learn more about efforts to improve cancer care and research and how to get involved

Health Equity: Resources to help the cancer community better understand and address health equity issues in oncology research and care

ASCO Association PAC: Learn more about the PAC

Massachusetts Society of Clinical Oncologists ©2023

860 Winter Street, Waltham, MA, 02451
Tel: 781.434.7329  |  email: msco@mms.org

Powered by Wild Apricot Membership Software